Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Am J Clin Nutr ; 104(3): 837-43, 2016 Sep.
Article En | MEDLINE | ID: mdl-27465372

BACKGROUND: Dietary soluble corn fiber (SCF) significantly improves calcium absorption in adolescents and the bone strength and architecture in rodent models. OBJECTIVE: In this study, we aimed to determine the skeletal benefits of SCF in postmenopausal women. DESIGN: We used our novel technology of determining bone calcium retention by following the urinary appearance of (41)Ca, a rare long-lived radioisotope, from prelabeled bone to rapidly and sensitively evaluate the effectiveness of SCF in reducing bone loss. A randomized-order, crossover, double-blinded trial was performed in 14 healthy postmenopausal women to compare doses of 0, 10, and 20 g fiber from SCF/d for 50 d. RESULTS: A dose-response effect was shown with 10 and 20 g fiber from SCF/d, whereby bone calcium retention was improved by 4.8% (P < 0.05) and 7% (P < 0.04), respectively. The bone turnover biomarkers N-terminal telopeptide and osteocalcin were not changed by the interventions; however, a significant increase in bone-specific alkaline phosphatase, which is a bone-formation marker, was detected between 0 and 20 g fiber from SCF/d (8%; P = 0.035). CONCLUSION: Daily SCF consumption significantly increased bone calcium retention in postmenopausal women, which improved the bone calcium balance by an estimated 50 mg/d. This study was registered at clinicaltrials.gov as NCT02416947.


Bone Density Conservation Agents/therapeutic use , Bone Remodeling , Dietary Fiber/therapeutic use , Food, Fortified , Osteoporosis, Postmenopausal/prevention & control , Zea mays/chemistry , Absorptiometry, Photon , Adult , Aged , Biomarkers/blood , Biomarkers/urine , Bone Density Conservation Agents/administration & dosage , Bone Density Conservation Agents/adverse effects , Calcium Radioisotopes , Cohort Studies , Cross-Over Studies , Dietary Fiber/administration & dosage , Dietary Fiber/adverse effects , Double-Blind Method , Female , Food, Fortified/adverse effects , Humans , Indiana , Middle Aged , Osteoporosis, Postmenopausal/diagnostic imaging , Osteoporosis, Postmenopausal/metabolism , Osteoporosis, Postmenopausal/urine , Prebiotics/administration & dosage , Prebiotics/adverse effects , Solubility , Whole Body Imaging
...